SHR-od is a novel strain of rat that spontaneously develops hypertension and has a defect of ascorbic acid (AsA) biosynthesis. The osteogenic disorder Shionogi (ODS) rat is normotensive and also unable to synthesize AsA. To investigate whether or not genetic hypertension affects AsA metabolism, we compared the AsA metabolisms of SHR-od and ODS rats. In this study, a physiological dose of AsA equivalent to the AsA requirement in ODS rats was administered to rats intraperitoneally (i.p. group) or orally (oral group). We measured AsA concentrations in the serum, liver, kidney, adrenal glands, and spleen, and the amount of AsA excreted into the urine. At 25 wk of age (hypertensive status), the AsA concentrations of all tissues tested were significantly lower in SHR-od than in ODS rats in both the i.p. and oral groups. In the i.p. group, the amount of urinary AsA in SHR-od was also lower than that in ODS rats. At 4 wk of age (before the onset of hypertension), liver and spleen AsA concentrations in SHR-od were lower than those in ODS rats in both the i.p. and oral groups. Urinary AsA excretion from SHR-od was not different between the two groups. Our data suggest that the requirement for AsA in SHR-od is increased to maintain tissue AsA concentrations equivalent to those in ODS rats, and that a larger part of the AsA ad ministered to rats in this study is degraded in SHR-od as compared to ODS rats.
Ascorbic acid (AsA) acts as a cofactor of some hy droxylases essential for collagen (1, 2) and cate cholamine biosynthesis (3). Moreover, AsA is a water soluble antioxidant and a free-radical scavenger. Therefore, it is estimated that the oxidation and subsequent degradation of AsA are accelerated under oxidative stress. We have reported (4) that treatment with lipopolysaccharide, which is recognized as an ex perimental model for oxidative stress, causes a marked reduction of tissue AsA concentration, for example, in the liver of osteogenic disorder Shionogi (ODS) rats un able to synthesize AsA, and that the bilirubin oxidation provoked by lipopolysaccharide treatment was sup pressed by feeding AsA to ODS rats. These results mean that AsA protects the body and organs against oxidative damage from oxidative stress.
Several studies have shown an inverse correlation be tween serum AsA concentration and blood pressure in human subjects (5) (6) (7) (8) and experimental animals (9) . Free-radical production and the oxidation process are involved in several aspects of the pathology of hyperten sion (10) . The spontaneously hypertensive rat (SHR) is * To whom correspondence should be addressed . E-mail; horiof@agr.nagoya-u.ac.jp Abbreviations; AsA, ascorbic acid; GSH-Px, glutathione peroxidase; ODS rat, osteogenic disorder Shionogi rat; SHR, spontaneously hypertensive rat; TBARS, thiobarbituric reac tive substance; WKY, Wistar-Kyoto rat. an available disease model for human essential hyper tension that was established from a colony of Wistar Kyoto rats (WKY) (11) . SHR and WKY are able to syn thesize enough AsA in the liver to maintain a high con centration of AsA in various tissues. The cardiac super oxide dismutase activity in SHR was reported to be lower than that in normotensive WKY (12) , and the level of superoxide anion in the SHR heart seems to be high. It has been hypothesized that a high level of su peroxide causes the cardiac hypertrophy observed in SHR (12) . Moreover, the vascular activity of NAD(P)H oxidase, which produces superoxide anion, is reported to be enhanced in SEW as compared to WKY (13) . The increased superoxide production caused by NAD(P)H oxidase enhancement may contribute to endothelial dysfunction (14, 15) and vascular hypertrophy (16) in SHR. These results also suggest that the increase in blood and tissue superoxide anion in SHR causes the consumption of physiological antioxidants such as AsA.
We have established a novel strain of SHR, SHR-od (17 ) with a hereditary defect of AsA biosynthesis through cross breeding with the ODS rat, which is a rat mutant unable to synthesize AsA due to a mutation of the L-gulono-7-lactone oxidase (EC 1.1.3.8) gene (18) , and have revealed several pathophysiological character istics of this unique model. SHR-od is a useful animal model for precisely investigating the interrelationship between hypertension and the AsA metabolism.
The objective of the present study was to examine the Experimental design. In experiment 1, male SHR-od and ODS rats 4 wk of age were divided into two groups of four animals each. In one group (i.p. group), rats were intraperitoneally (i.p.) injected with ascorbic acid at a dose of 54.6mg (dissolved in 0.9% saline) per kg body weight once a day for 14 d. In the other group (oral group), rats were orally administered the same dose of ascorbic acid in 0.9% saline by stomach tube (KN-349 01.5mm, Natsume Seisakusyo, Tokyo, Japan) once a day for 14 d. These treatments were performed at 6p.m. every day.
In experiment 2, male SHR-od and ODS rats 2 5 wk of age were divided into two groups of four animals each. In one group (i.p. group), rats were intraperitoneally in jected with AsA at a dose of 18.3mg (dissolved in 0.9% saline) per kg of body weight once a day for 21 d. In the other group (oral group), rats were orally administrated the same dose of ascorbic acid in 0.9% saline by stom ach tube (KN-349 01.7mm, Natsume Seisakusyo) once a day for 21 d. These treatments were performed at 6 p.m. every day.
Feeding a diet containing 300 mg AsA per kg pre vents the development of scurvy in ODS rats (19) and SHR-od (17) . When ODS rats and SHR-od were fed this diet ad libitum at 4wk of age, their daily AsA intake was measured as 54.6mg per kg body weight. At 25 wk of age, the daily AsA intake in ODS rats and SHR-od was measured as 18.3mg per kg body weight. In this study, the daily dose of AsA in each experiment was deter mined using these results.
All rats were fed a Funabashi-SP diet (Funabashi Farm, Chiba, Japan) during the experimental period. The composition of the diet is as follows: crude protein, 20.8%; crude fat, 4.8%; nitrogen-free extract, 58.2%; crude ash, 5.0%; crude fiber, 3.2%; moisture, 8.0%. Since Funabashi-SP diet contains a negligible amount of AsA, feeding this diet causes scurvy in ODS rats and SHR-od. All rats were allowed free access to the diet and water. Systolic blood pressure was measured by the tail pulse pick-up method without anesthesia using an au tomatic blood pressure monitoring system (BP-98A,
Softron
Co., Ltd., Tokyo, Japan Determination of urinary creatinine level. Urinary creatinine was determined using a commercial kit (Creatinine-Test Wako, Wako Pure Chemical Industries, Ltd., Osaka, Japan).
Determination of lipid peroxidation in liver and serum. The degree of lipid oxidation in the liver and serum was measured using the thiobarbituric acid reactive sub stance (TBARS) assay. The frozen liver was homoge nized with 10 vol of ice-cold 1.15% KCl, and the TBARS assay was performed using the method of Ohkawa et al. (21) . 
RESULTS
Experiment 1 (at 4wk of age) As shown in Table 1 , body weight was significantly lower in SHR-od than in ODS rats at 4wk of age. There were no significant differences in systolic blood pressure between ODS rats and SHR-od during the course of the experiment. Moreover, the differences in the route of AsA administration did not affect the systolic blood pressure of ODS rats or SHR-od. Serum AsA concentrations were not different be tween ODS rats and SHR-od in either the i.p. or oral groups (Fig. 1A) . In the i.p. groups, kidney and adrenal AsA concentrations were not different between ODS rats and SHR-od ( Fig. lB and 1E ). However, in the oral groups, kidney and adrenal AsA concentrations were significantly lower in SHR-od than in ODS rats. Hepatic and spleen AsA concentrations in SHR-od were signifi cantly lower than those in ODS rats in both the i.p. and oral groups (Fig. 1C and 1D ).
Urinary excretion
of AsA and creatinine is shown in Fig. 2A and 2B , respectively.
The amounts of urinary
AsA and urinary creatinine were not different between ODS rats and SHR-od in either the i.p. or oral groups.
The amount of AsA excreted by SHR-od was 2 7% of the administered AsA in the i.p. groups and 0.9% in the oral groups.
As shown in Fig. 3A , the hepatic TBARS level tended to be higher in SHR-od as compared to that in ODS rats, but not significantly. Hepatic GSH-Px activity was lower in SHR-od than in ODS rats (significant in the oral group, but not significant in the i.p. group). Experiment 2 (at 25wk of age) At 25wk of age, body weight was not different be tween the ODS rats and SHR-od ( Table 1 ). The systolic blood pressure of SHR-od was significantly higher than that of ODS rats. The differences in the route of AsA ad ministration did not affect the systolic blood pressure of either ODS rats or SHR-od.
The serum AsA concentration in SHR-od was signifi cantly lower than that in ODS rats in the i.p. group (Fig. 1A). On the other hand, in all tissues tested (kidney, liver, spleen, and adrenal glands), AsA concentrations in SHR-od were significantly lower than those in ODS rats in both the i.p. and oral groups (Fig. 1B, 1C , 1D, and 1E, respectively). As shown in Fig. 2A , in the i.p. groups, the amount of urinary AsA from SHR-od was significantly lower (34% of the amount in ODS rats) than that from ODS rats. In the oral groups, as the amount of urinary AsA was markedly low, a difference was not observed between ODS rats and SHR-od. The amount of creatinine was not different between ODS rats and SHR-od (Fig. 2B) .
The hepatic TBARS level in the i.p. group was signifi cantly higher in SHR-od than that in ODS rats, but was not significant in the oral group (Fig. 3A) . Hepatic GSH Px activity in SHR-od was significantly lower than that in ODS rats in both the i.p. and oral groups (Fig. 3B) . DISCUSSION ODS rats with a hereditary defect of AsA biosynthesis are a useful model for determining the requirement for this vitamin under various conditions. In young adult ODS rats, the dietary addition of about 300mg AsA per kg of diet is sufficient to prevent signs of scurvy and to achieve maximum growth (19) . In addition to ODS rats, we (17) established a novel SHR strain unable to synthesize AsA, SHR-od, and reported that the dietary addition of 300mg AsA per kg of diet is also sufficient to prevent scurvy in SHR-od. SHR-od develops sponta neous hypertension from around 10wk of age, and the systolic blood pressure of SHR-od reaches 180 200mmHg at 20wk of age (17) . With the establish ment of SHR-od, it has become possible to examine the effects of the genetic background of spontaneous hyper tension or the effect of the development of hypertension on AsA metabolism under the physiological intake of this vitamin. At 25wk of age, the systolic blood pressure of SHR od was markedly higher than that of ODS rats, and SHR-od had been exposed to hypertension since around 16wk of age. After the experimental period, the AsA concentrations in all tissues tested were markedly lower in SHR-od than those in ODS rats in both the i.p. and oral groups. The serum concentration of AsA in the i.p. group also tended to be lower in SHR-od as compared to ODS rats. In the oral groups, there was no difference in serum AsA concentration between the two strains, be cause the concentrations were markedly low. In a previ ous study (17) , we reported that serum and hepatic concentrations of AsA were also lower in hypertensive SHR-od than those in ODS rats under feeding a diet containing 300 mg AsA per kg ad libitum. AsA itself and the AsA metabolites produced via its degradation pathway were excreted into the urine at a constant rate. In the i.p. groups, the amount of AsA daily excreted into the urine of SHR-od was 34% of that of ODS rats (the difference was significant, p<0.05). There was no dif ference in urinary amount of AsA between the two strains in the oral groups, because the amount of uri nary AsA in these groups was too low. Recently, it has been reported that hypertension causes oxidative stress in some organs (27) (28) (29) (30) . In our analysis of hepatic TBARS (Fig. 3) , indicating the con centration of lipid peroxide, we found that the level of TBARS in SHR-od at 6 wk of age tended to be higher than that in ODS rats, and the level at 2 8 wk of age was higher. This analysis also demonstrated that hepatic TBARS in SHR-od increased during a 22-wk period, from 6 to 28wk of age, but did not change in ODS rats. On the other hand, the hepatic activity of GSH-Px, which reduces peroxide using glutathione, was slightly lower in SHR-od than in ODS rats at 6wk of age. The activity in ODS rats increased during the subsequent 22wk, but did not change in SHR-od. Thus, the lower activity of hepatic GSH-Px in SHR-od at 6wk of age might contribute the higher level of hepatic TBARS as compared to ODS rats, and the impairment of the in crease in the hepatic activity of GSH-Px during the sub sequent 22wk in SHR-od might cause the elevation of hepatic TBARS. Vericel et al. also demonstrated a lower activity of hepatic GSH-Px in SHR as compared to WKY (31) . Moreover, it has been pointed out by Murakami et al. (32) that erythrocyte GSH-Px activity changed with the development of hypertension and stroke in stroke prone SHR. This taken together, it is speculated that ox idative stress is caused in the liver of SHR-od, leading to the acceleration of AsA oxidation. It has been reported that the plasma level of AsA is decreased under an ox idatively stressed condition, such as cerebral ischemia (33) (34) (35) , myocardial infarction (36) , and inflammation (4). In further studies, the level of dehydroascorbic acid and subsequent metabolites in various organs including the liver should be compared between SHR-od and ODS rats.
In this study, it was demonstrated for the first time that the tissue AsA concentrations and urinary excre tion of AsA in SHR-od are lower than those in ODS rats. This means that the requirement for AsA might be in creased to maintain indispensable levels of AsA in the serum and tissues in SHR-od and hypertensive subjects. Further study is needed to confirm that AsA degrada tion is accelerated in SHR-od as compared to ODS rats. 
